Document resource
The renaming of polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) recognises the condition’s broader endocrine and metabolic aspects.1 These include insulin resistance, androgen excess, and increased risks of diabetes and cardiovascular disease.